Jonathan Paris - 01 Jul 2025 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Reporting owner
Signature
/s/ Jonathan Paris
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
02 Jul 2025, 16:30:17 UTC
Previous filing
18 Jun 2025
Next filing
26 Feb 2026
SEC filing
View on sec.gov

Key filing fact

Jonathan Paris filed Form 4 for Definitive Healthcare Corp. (DH) on 02 Jul 2025.

Key facts

  • This page summarizes Jonathan Paris's Form 4 filing for Definitive Healthcare Corp. (DH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 02 Jul 2025, 16:30.

Change

  • Previous filing in this sequence was filed on 18 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001866482 Primary reporting owner

Paris Jonathan

Relationship
Chief Legal Officer
Address
C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Signature
/s/ Jonathan Paris
Signature date
02 Jul 2025

Reported transactions

DH transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+421,349
Change %
Price
$0.000000
Shares after
421,349
Date
01 Jul 2025
Ownership
Direct
Footnotes
F1
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on July 1, 2026, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .